Shanghai Shenqi Pharmaceutical Investment Management Co (SHSE:600613) Margin of Safety % (DCF Earnings Based): N/A (As of Jul. 06, 2026)


SHSE:600613 Shanghai Shenqi Pharmaceutical Investment Management Co Ltd SHSE:600613
53 GF Score
Price ¥4.82
GF Value ¥5.44
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Shanghai Shenqi Pharmaceutical Investment Management Co Margin of Safety % (DCF Earnings Based)?

Margin of Safety % (DCF Earnings Based) = (Intrinsic Value: DCF (Earnings Based) - Current Price) / Intrinsic Value: DCF (Earnings Based).

Note: Discounted Earnings model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

Shanghai Shenqi Pharmaceutical Investment Management Co's Predictability Rank is 1-Star. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF Earnings Based) is not calculated.

SHSE:600613 vs LLY, JNJ, ABBV: Margin of Safety % (DCF Earnings Based) Comparison

For the Drug Manufacturers - General subindustry, Shanghai Shenqi Pharmaceutical Investment Management Co's Margin of Safety % (DCF Earnings Based), along with its competitors' market caps and Margin of Safety % (DCF Earnings Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Shanghai Shenqi Pharmaceutical Investment Management Co Margin of Safety % (DCF Earnings Based) vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Shanghai Shenqi Pharmaceutical Investment Management Co's Margin of Safety % (DCF Earnings Based) distribution charts can be found below:

* The bar in red indicates where Shanghai Shenqi Pharmaceutical Investment Management Co's Margin of Safety % (DCF Earnings Based) falls into.


SHSE:600613
53GF Score
Shanghai Shenqi Pharmaceutical Investment Management Co Ltd SHSE:600613
Margin of Safety % (DCF Earnings Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Shanghai Shenqi Pharmaceutical Investment Management Co (SHSE:600613) Overvalued in 2026?

Based on GuruFocus' analysis, Shanghai Shenqi Pharmaceutical Investment Management Co stock appears to be undervalued. The current stock price of ¥4.82 is trading 11.4% below its estimated GF Value™ of ¥5.44. GuruFocus considers Shanghai Shenqi Pharmaceutical Investment Management Co to be Modestly Undervalued.

Key valuation signals for SHSE:600613:

  • Margin of Safety % (DCF Earnings Based): N/A
  • GF Value™: ¥5.44 vs. price of ¥4.82 (11.4% below fair value)
  • GF Score™: 53/100 with 5 warning signs

No single metric tells the full story. See the SHSE:600613 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Shanghai Shenqi Pharmaceutical Investment Management Co Business Description

Other Exchanges 900904:China
Address 128 Weihai Road, Room 613, Changfa Building, Shanghai, CHN, 200003
Shanghai Shenqi Pharmaceutical Investment Management Co Ltd is mainly engaged in pharmaceutical production and distribution in China.
53GF Score

Get the complete analysis for SHSE:600613

Margin of Safety % (DCF Earnings Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥4.82
Price
¥5.44
GF Value